Webinar On Demand

pART 2 WEBINAR - Comprehensive and integrated formulation drug development case study

In part two of our E.SOLVE webinar series, our formulation experts John Nkornu and Zsolt Lendvai take you through a recent case study and demonstrate how an integrated formulation strategy from the preclinical phase can solve complex bioavailability problems, increase probability of success, and accelerate time to clinical phase.

In particular they cover:

• End-to-end support
• Fully integrated screening approach
• Early formulation screening
• Pharmacokinetics and dose range finding

Learn More About Our Speakers

John M Nkornu, Senior Research Expert in Pharmaceutical Development at Evotec

John M Nkornu is Senior Research Expert in Pharmaceutical Development at Evotec where he provides technical support for both clinical and pre-clinical formulation development. He has 19 years of experience in the pharmaceutical industry and joined Evotec in March 2021.

John is an expert in oral solid/liquid, lipid based formulations, parenteral, topical formulation development and paediatric formulation development. He holds a BSc in biochemistry from University of Ghana and did his MSc in pharmaceutical science at Aston University. During his MSc John worked on the effect of CNK1 on the canonical and the non-canonical NF-KB signalling pathway.

Zsolt Lendvai,  Research Leader, Formulation Development Projects at Evotec

Zsolt has 19 years of experience in the pharmaceutical industry in commercial manufacturing and R&D of generic and novel drug products. He is an expert in GMP manufacturing of both commercial and pilot/pivotal phase drug products for bioequivalence studies and has strong knowledge of liquid, semi-solid and oral solid dosage forms manufacturing technology and formulation development, as well as pilot plant management skills.

Zsolt has a Degree in Biotechnology from the University of Debrecen, Hungary, and prior to joining Evotec he was Senior Formulation Scientist at Teva Pharmaceuticals Ltd.